Literature DB >> 8758910

Hybrid selection of transcribed sequences from microdissected DNA: isolation of genes within amplified region at 20q11-q13.2 in breast cancer.

X Y Guan1, J Xu, S L Anzick, H Zhang, J M Trent, P S Meltzer.   

Abstract

In human breast carcinomas, increased copy number of DNA sequences derived from the long arm of chromosome 20 (20q) has been commonly observed by both chromosome microdissection and comparative genomic hybridization. This chromosomal region is likely to contain one or more genes that are the biological targets of this amplification event. We describe here the utilization of a chromosome microdissection-hybrid selection strategy to isolate transcribed sequences from microdissected homogeneously staining regions encompassing 20q. Using this strategy, we have isolated three novel amplified genes (termed AIB1, AIB3, and AIB4) from a cDNA library constructed from the 20q amplified breast cancer cell line BT-474. These three genes were mapped to 20q11 (AIB3 and AIB4) and 20q12 (AIB1) by fluorescence in situ hybridization. Our results indicate an unsuspected complexity to the amplification pattern of 20q in breast cancer and provide probes that will be useful for further characterization of tumor specimens.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8758910

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  35 in total

1.  AIB1 polymorphisms with breast cancer susceptibility: a pooled analysis of variation in BRCA1/2 mutation carriers and non-carriers.

Authors:  Ying Zhang; Meiyan Huang; Zhenglan Zhu
Journal:  Mol Biol Rep       Date:  2012-02-04       Impact factor: 2.316

2.  A tumor suppressive coactivator complex of p53 containing ASC-2 and histone H3-lysine-4 methyltransferase MLL3 or its paralogue MLL4.

Authors:  Jeongkyung Lee; Dae-Hwan Kim; Seunghee Lee; Qi-Heng Yang; Dong Kee Lee; Soo-Kyung Lee; Robert G Roeder; Jae W Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-11       Impact factor: 11.205

3.  Activating signal cointegrator 2 belongs to a novel steady-state complex that contains a subset of trithorax group proteins.

Authors:  Young-Hwa Goo; Young Chang Sohn; Dae-Hwan Kim; Seung-Whan Kim; Min-Jung Kang; Dong-Ju Jung; Eunyee Kwak; Nickolai A Barlev; Shelley L Berger; Vincent T Chow; Robert G Roeder; David O Azorsa; Paul S Meltzer; Pan-Gil Suh; Eun Joo Song; Kong-Joo Lee; Young Chul Lee; Jae Woon Lee
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

4.  Role of nuclear receptor coactivator 3 (Ncoa3) in pluripotency maintenance.

Authors:  Zhaoting Wu; Meng Yang; Hongjie Liu; Hongchao Guo; Yuan Wang; Hong Cheng; Lingyi Chen
Journal:  J Biol Chem       Date:  2012-09-12       Impact factor: 5.157

Review 5.  The role of SRC-3 in human breast cancer.

Authors:  Ondrej Gojis; Bharath Rudraraju; Mihir Gudi; Katy Hogben; Sami Sousha; R Charles Coombes; Charles R Coombes; Susan Cleator; Carlo Palmieri
Journal:  Nat Rev Clin Oncol       Date:  2009-12-22       Impact factor: 66.675

Review 6.  Roles of histone H3-lysine 4 methyltransferase complexes in NR-mediated gene transcription.

Authors:  Seunghee Lee; Robert G Roeder; Jae W Lee
Journal:  Prog Mol Biol Transl Sci       Date:  2009-10-07       Impact factor: 3.622

Review 7.  Molecular characterization and pathogenesis of gastrointestinal stromal tumor.

Authors:  Takeshi Niinuma; Hiromu Suzuki; Tamotsu Sugai
Journal:  Transl Gastroenterol Hepatol       Date:  2018-01-09

8.  Somatic instability of the DNA sequences encoding the polymorphic polyglutamine tract of the AIB1 gene.

Authors:  P Dai; L-J C Wong
Journal:  J Med Genet       Date:  2003-12       Impact factor: 6.318

9.  Selective estrogen receptor modulators 4-hydroxytamoxifen and raloxifene impact the stability and function of SRC-1 and SRC-3 coactivator proteins.

Authors:  David M Lonard; Sophia Y Tsai; Bert W O'Malley
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

Review 10.  Steroid receptor coactivator-3 as a potential molecular target for cancer therapy.

Authors:  Jean Ching-Yi Tien; Jianming Xu
Journal:  Expert Opin Ther Targets       Date:  2012-08-27       Impact factor: 6.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.